Skip to main content
See every side of every news story
Published loading...Updated

Trump Starts Fifty Billion in Pharmaceutical Investments · Global Voices

Summary by Expansión
In just over a year, groups like AbbVie, Pfizer, AstraZeneca, J&J, Roche, Novartis, GSK or Lilly sign million-dollar investments to lower prices, production and R & D in exchange for exemptions. Read
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

In just over a year, groups like AbbVie, Pfizer, AstraZeneca, J&J, Roche, Novartis, GSK or Lilly sign million-dollar investments to lower prices, production and R & D in exchange for exemptions. Read

·Madrid, Spain
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Expansión broke the news in Madrid, Spain on Sunday, September 6, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal